Knight Therapeutics Stock Price on November 28, 2024
| GUD Stock | CAD 5.27 0.05 0.96% |
Below is the normalized historical share price chart for Knight Therapeutics extending back to March 03, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Knight Therapeutics stands at 5.27, as last reported on the 2nd of December, with the highest price reaching 5.30 and the lowest price hitting 5.23 during the day.
If you're considering investing in Knight Stock, it is important to understand the factors that can impact its price. Knight Therapeutics has Sharpe Ratio of -0.0178, which conveys that the firm had a -0.0178% return per unit of risk over the last 3 months. Knight Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Knight Therapeutics' Risk Adjusted Performance of (0.01), standard deviation of 2.11, and Mean Deviation of 1.26 to check out the risk estimate we provide.
At this time, Knight Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 2nd of December 2024, Common Stock Shares Outstanding is likely to grow to about 123.8 M, while Other Stockholder Equity is likely to drop about 17.1 M. . As of the 2nd of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.90, while Price To Sales Ratio is likely to drop 1.61. Knight Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Knight |
Sharpe Ratio = -0.0178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GUD |
Estimated Market Risk
| 2.14 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Knight Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Knight Therapeutics by adding Knight Therapeutics to a well-diversified portfolio.
Knight Therapeutics Valuation on November 28, 2024
It is possible to determine the worth of Knight Therapeutics on a given historical date. On November 28, 2024 Knight was worth 5.22 at the beginning of the trading date compared to the closed value of 5.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Knight Therapeutics stock. Still, in general, we apply an absolute valuation method to find Knight Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Knight Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Knight Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 5.25 | 5.31 | 5.24 | 5.27 | 63,468 | |
11/28/2024 | 5.22 | 5.29 | 5.22 | 5.22 | 27,931 |
| 5.23 | 5.30 | 5.23 | 5.27 | 41,113 |
| Backtest Knight Therapeutics | | | Knight Therapeutics History | | | Knight Therapeutics Valuation | Previous | Next |
Knight Therapeutics Trading Date Momentum on November 28, 2024
| On November 29 2024 Knight Therapeutics was traded for 5.27 at the closing time. The maximum traded price for the trading interval was 5.30 and the lowest daily price was 5.23 . The daily volume was recorded at 41.1 K. The volume of trading on 29th of November 2024 played a part in the next trading day price boost. The overall trading delta to the next closing price was 0.96% . The trading delta at closing time to the closing price today is 0.19% . |
Knight Therapeutics Fundamentals Correlations and Trends
By evaluating Knight Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Knight Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Knight financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Knight Therapeutics Stock history
Knight Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Knight is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Knight Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Knight Therapeutics stock prices may prove useful in developing a viable investing in Knight Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 107.5 M | 123.8 M |
Knight Therapeutics Stock Technical Analysis
Knight Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Knight Therapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Knight Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Knight Therapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Knight Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Knight Therapeutics shares will generate the highest return on investment. By undertsting and applying Knight Therapeutics stock market strength indicators, traders can identify Knight Therapeutics entry and exit signals to maximize returns
Knight Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Knight Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Knight Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Knight to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | 0.0985 | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | 0.0486 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Knight Stock
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.